M&A Deal Summary

CURE Pharmaceutical Holding Acquires Sera Labs

On July 30, 2020, CURE Pharmaceutical Holding acquired medical products company Sera Labs for 20M USD

Acquisition Highlights
  • This is CURE Pharmaceutical Holding’s 1st transaction in the Medical Products sector.
  • This is CURE Pharmaceutical Holding’s largest (disclosed) transaction.
  • This is CURE Pharmaceutical Holding’s 1st transaction in the United States.
  • This is CURE Pharmaceutical Holding’s 1st transaction in Maryland.

M&A Deal Summary
Date 2020-07-30
Target Sera Labs
Sector Medical Products
Buyer(s) CURE Pharmaceutical Holding
Deal Type Add-on Acquisition
Deal Value 20M USD

Target

Sera Labs

Lewiston, Maryland, United States
Sera Labs, Inc. is a CBD health and wellness company. Sera Labs is based is Lewiston, Maryland.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

CURE Pharmaceutical Holding

Oxnard, California, United States
Category Company
Founded 2011
Sector Life Science
DESCRIPTION

CURE Pharmaceutical Holding Corp. is a developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients. CURE Pharmaceutical Holding was founded in 2011 and is based in Oxnard, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Maryland) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal